Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Evid Based Child Health
; 9(1): 169-294, 2014 Mar.
Article
en En
| MEDLINE
| ID: mdl-25404581
*HIV Seronegativity; Antibiotics, Antitubercular [*therapeutic use]; Directly Observed Therapy; Drug Administration Schedule; Isoniazid [therapeutic use]; Latent Tuberculosis [*drug therapy]; Randomized Controlled Trials as Topic; Rifabutin [*therapeutic use]; Rifampin [*analogs & derivatives; *therapeutic use]; Tuberculosis, Pulmonary [*prevention & control]
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Idioma:
En
Revista:
Evid Based Child Health
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Reino Unido